{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T00:43:16Z","timestamp":1786840996878,"version":"build-2736575974"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:00:00Z","timestamp":1723161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:00:00Z","timestamp":1723161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Solitary fibrous tumor (SFT) is a rare fibroblastic mesenchymal neoplasm. The current classification has merged SFT and hemangiopericytoma (HPC) into the same tumor entity, while the risk stratification models have been developed to compensate for clinical prediction. Typically, slow-growing and asymptomatic, SFT can occur in various anatomical sites, most commonly in the pleura. Histologically, SFT consists of spindle to oval cells with minimal patterned growth, surrounded by stromal collagen and unique vascular patterns. Molecularly, SFT is defined by the fusion of NGFI-A-binding protein 2 (NAB2) and signal transducer and activator of transcription 6 (STAT6) genes as NAB2-STAT6. This fusion transforms NAB2 into a transcriptional activator, activating early growth response 1 (EGR1) and contributing to SFT pathogenesis and development. There are several fusion variants of NAB2-STAT6 in tumor tissues, with the most frequent ones being NAB2ex4-STAT6ex2 and NAB2ex6-STAT6ex16\/ex17. Diagnostic methods play a crucial role in SFT clinical practice and basic research, including RT-PCR, next-generation sequencing (NGS), FISH, immunohistochemistry (IHC), and Western blot analysis, each with distinct capabilities and limitations. Traditional treatment strategies of SFT encompass surgical resection, radiation therapy, and chemotherapy, while emerging management regimes include antiangiogenic agents, immunotherapy, RNA-targeting technologies, and potential targeted drugs. This review provides an update on SFT's clinical and molecular aspects, diagnostic methods, and potential therapies.<\/jats:p>","DOI":"10.1007\/s10555-024-10204-8","type":"journal-article","created":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T04:02:07Z","timestamp":1723176127000},"page":"1337-1352","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Advances in the molecular biology of the solitary fibrous tumor and potential impact on clinical applications"],"prefix":"10.1007","volume":"43","author":[{"given":"Chongmin","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"D\u2019Amato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis J.","family":"Hornicek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenfeng","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,9]]},"reference":[{"issue":"1","key":"10204_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ajim.4700220103","volume":"22","author":"P Klemperer","year":"1992","unstructured":"Klemperer, P., & Coleman, B. R. (1992). Primary neoplasms of the pleura. A report of five cases. American Journal of Industrial Medicine, 22(1), 1\u201331. https:\/\/doi.org\/10.1002\/ajim.4700220103","journal-title":"American Journal of Industrial Medicine"},{"issue":"1","key":"10204_CR2","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/00000658-195101000-00005","volume":"133","author":"AP Stout","year":"1951","unstructured":"Stout, A. P., & Himadi, G. M. (1951). Solitary (localized) mesothelioma of the pleura. Annals of Surgery, 133(1), 50\u201364. https:\/\/doi.org\/10.1097\/00000658-195101000-00005","journal-title":"Annals of Surgery"},{"issue":"1","key":"10204_CR3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/00000658-194207000-00004","volume":"116","author":"AP Stout","year":"1942","unstructured":"Stout, A. P., & Murray, M. R. (1942). Hemangiopericytoma: A vascular tumor featuring Zimmermann\u2019s Pericytes. Annals of Surgery, 116(1), 26\u201333. https:\/\/doi.org\/10.1097\/00000658-194207000-00004","journal-title":"Annals of Surgery"},{"key":"10204_CR4","doi-asserted-by":"publisher","unstructured":"Stout, A. P. (1949). Hemangiopericytoma; a study of 25 cases. Cancer, 2(6), 1027\u20131054. https:\/\/doi.org\/10.1002\/1097-0142(194911)2:6%3c1027::aid-cncr2820020609%3e3.0.co;2-r","DOI":"10.1002\/1097-0142(194911)2:6%3c1027::aid-cncr2820020609%3e3.0.co;2-r"},{"issue":"1","key":"10204_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1365-2559.2005.02290.x","volume":"48","author":"C Gengler","year":"2006","unstructured":"Gengler, C., & Guillou, L. (2006). Solitary fibrous tumour and haemangiopericytoma: Evolution of a concept. Histopathology, 48(1), 63\u201374. https:\/\/doi.org\/10.1111\/j.1365-2559.2005.02290.x","journal-title":"Histopathology"},{"issue":"1","key":"10204_CR6","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13000-021-01095-2","volume":"16","author":"MU Tariq","year":"2021","unstructured":"Tariq, M. U., Din, N. U., Abdul-Ghafar, J., & Park, Y.-K. (2021). The many faces of solitary fibrous tumor; diversity of histological features, differential diagnosis and role of molecular studies and surrogate markers in avoiding misdiagnosis and predicting the behavior. Diagnostic Pathology, 16(1), 32. https:\/\/doi.org\/10.1186\/s13000-021-01095-2","journal-title":"Diagnostic Pathology"},{"issue":"27","key":"10204_CR7","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.2217\/fon-2021-0030","volume":"17","author":"A Smrke","year":"2021","unstructured":"Smrke, A., Thway, K. P. H. H., Jones, R. L., & Hayes, A. J. (2021). Solitary fibrous tumor: molecular hallmarks and treatment for a rare sarcoma. Future Oncology, 17(27), 3627\u20133636. https:\/\/doi.org\/10.2217\/fon-2021-0030","journal-title":"Future Oncology"},{"key":"10204_CR8","unstructured":"WHO. (2020). Classification of tumours soft tissue and bone tumours (5th ed., Vol. 3). IARC Press."},{"issue":"8","key":"10204_CR9","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis, D. N., Perry, A., Wesseling, P., Brat, D. J., Cree, I. A., Figarella-Branger, D., et al. (2021). The 2021 WHO Classification of Tumors of the Central Nervous System: A summary. Neuro-Oncology, 23(8), 1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106","journal-title":"Neuro-Oncology"},{"issue":"1","key":"10204_CR10","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/pas.0000000000001552","volume":"45","author":"ME Kallen","year":"2021","unstructured":"Kallen, M. E., & Hornick, J. L. (2021). The 2020 WHO classification: What\u2019s new in soft tissue tumor pathology? The American Journal of Surgical Pathology, 45(1), e1\u2013e23. https:\/\/doi.org\/10.1097\/pas.0000000000001552","journal-title":"The American Journal of Surgical Pathology"},{"issue":"3","key":"10204_CR11","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.soc.2022.03.009","volume":"31","author":"K Kazazian","year":"2022","unstructured":"Kazazian, K., Demicco, E. G., de Perrot, M., Strauss, D., & Swallow, C. J. (2022). Toward Better Understanding and Management of Solitary Fibrous Tumor. Surgical Oncology Clinics of North America, 31(3), 459\u2013483. https:\/\/doi.org\/10.1016\/j.soc.2022.03.009","journal-title":"Surgical Oncology Clinics of North America"},{"key":"10204_CR12","doi-asserted-by":"publisher","unstructured":"de Bernardi, A., Dufresne, A., Mishellany, F., Blay, J. Y., Ray-Coquard, I., & Brahmi, M. (2022). Novel therapeutic options for solitary fibrous tumor: Antiangiogenic therapy and beyond. Cancers (Basel), 14(4). https:\/\/doi.org\/10.3390\/cancers14041064","DOI":"10.3390\/cancers14041064"},{"issue":"2","key":"10204_CR13","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/ng.2509","volume":"45","author":"DR Robinson","year":"2013","unstructured":"Robinson, D. R., Wu, Y. M., Kalyana-Sundaram, S., Cao, X., Lonigro, R. J., Sung, Y. S., et al. (2013). Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing. Nature Genetics, 45(2), 180\u2013185. https:\/\/doi.org\/10.1038\/ng.2509","journal-title":"Nature Genetics"},{"issue":"10","key":"10204_CR14","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/gcc.22083","volume":"52","author":"A Mohajeri","year":"2013","unstructured":"Mohajeri, A., Tayebwa, J., Collin, A., Nilsson, J., Magnusson, L., von Steyern, F. V., et al. (2013). Comprehensive genetic analysis identifies a pathognomonic NAB2\/STAT6 fusion gene, nonrandom secondary genomic imbalances, and a characteristic gene expression profile in solitary fibrous tumor. Genes, Chromosomes & Cancer, 52(10), 873\u2013886. https:\/\/doi.org\/10.1002\/gcc.22083","journal-title":"Genes, Chromosomes & Cancer"},{"issue":"2","key":"10204_CR15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/ng.2522","volume":"45","author":"J Chmielecki","year":"2013","unstructured":"Chmielecki, J., Crago, A. M., Rosenberg, M., O\u2019Connor, R., Walker, S. R., Ambrogio, L., et al. (2013). Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors. Nature Genetics, 45(2), 131\u2013132. https:\/\/doi.org\/10.1038\/ng.2522","journal-title":"Nature Genetics"},{"issue":"10","key":"10204_CR16","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1007\/s00109-019-01815-8","volume":"97","author":"HK Park","year":"2019","unstructured":"Park, H. K., Yu, D. B., Sung, M., Oh, E., Kim, M., Song, J. Y., et al. (2019). Molecular changes in solitary fibrous tumor progression. Journal of Molecular Medicine (Berlin, Germany), 97(10), 1413\u20131425. https:\/\/doi.org\/10.1007\/s00109-019-01815-8","journal-title":"Journal of Molecular Medicine (Berlin, Germany)"},{"issue":"2","key":"10204_CR17","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/cam4.572","volume":"5","author":"SC Huang","year":"2016","unstructured":"Huang, S. C., Li, C. F., Kao, Y. C., Chuang, I. C., Tai, H. C., Tsai, J. W., et al. (2016). The clinicopathological significance of NAB2-STAT6 gene fusions in 52 cases of intrathoracic solitary fibrous tumors. Cancer Medicine, 5(2), 159\u2013168. https:\/\/doi.org\/10.1002\/cam4.572","journal-title":"Cancer Medicine"},{"issue":"5","key":"10204_CR18","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/pin.12408","volume":"66","author":"IC Chuang","year":"2016","unstructured":"Chuang, I. C., Liao, K. C., Huang, H. Y., Kao, Y. C., Li, C. F., Huang, S. C., et al. (2016). NAB2-STAT6 gene fusion and STAT6 immunoexpression in extrathoracic solitary fibrous tumors: The association between fusion variants and locations. Pathology International, 66(5), 288\u2013296. https:\/\/doi.org\/10.1111\/pin.12408","journal-title":"Pathology International"},{"issue":"9","key":"10204_CR19","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1038\/modpathol.2012.83","volume":"25","author":"EG Demicco","year":"2012","unstructured":"Demicco, E. G., Park, M. S., Araujo, D. M., Fox, P. S., Bassett, R. L., Pollock, R. E., et al. (2012). Solitary fibrous tumor: A clinicopathological study of 110 cases and proposed risk assessment model. Modern Pathology, 25(9), 1298\u20131306. https:\/\/doi.org\/10.1038\/modpathol.2012.83","journal-title":"Modern Pathology"},{"issue":"10","key":"10204_CR20","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1038\/modpathol.2017.54","volume":"30","author":"EG Demicco","year":"2017","unstructured":"Demicco, E. G., Wagner, M. J., Maki, R. G., Gupta, V., Iofin, I., Lazar, A. J., et al. (2017). Risk assessment in solitary fibrous tumors: Validation and refinement of a risk stratification model. Modern Pathology, 30(10), 1433\u20131442. https:\/\/doi.org\/10.1038\/modpathol.2017.54","journal-title":"Modern Pathology"},{"issue":"8","key":"10204_CR21","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1093\/annonc\/mdx250","volume":"28","author":"S Salas","year":"2017","unstructured":"Salas, S., Resseguier, N., Blay, J. Y., Le Cesne, A., Italiano, A., Chevreau, C., et al. (2017). Prediction of local and metastatic recurrence in solitary fibrous tumor: Construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) database. Annals of Oncology, 28(8), 1979\u20131987. https:\/\/doi.org\/10.1093\/annonc\/mdx250","journal-title":"Annals of Oncology"},{"issue":"1","key":"10204_CR22","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/his.14078","volume":"77","author":"T Georgiesh","year":"2020","unstructured":"Georgiesh, T., Boye, K., & Bjerkehagen, B. (2020). A novel risk score to predict early and late recurrence in solitary fibrous tumour. Histopathology, 77(1), 123\u2013132. https:\/\/doi.org\/10.1111\/his.14078","journal-title":"Histopathology"},{"issue":"1","key":"10204_CR23","doi-asserted-by":"publisher","first-page":"7479","DOI":"10.1038\/s41467-023-43249-4","volume":"14","author":"R Zhang","year":"2023","unstructured":"Zhang, R., Yang, Y., Hu, C., Huang, M., Cen, W., Ling, D., et al. (2023). Comprehensive analysis reveals potential therapeutic targets and an integrated risk stratification model for solitary fibrous tumors. Nature Communications, 14(1), 7479. https:\/\/doi.org\/10.1038\/s41467-023-43249-4","journal-title":"Nature Communications"},{"issue":"6","key":"10204_CR24","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1097\/pas.0000000000001027","volume":"42","author":"P Feasel","year":"2018","unstructured":"Feasel, P., Al-Ibraheemi, A., Fritchie, K., Zreik, R. T., Wang, W. L., Demicco, E., et al. (2018). Superficial solitary fibrous tumor: A series of 26 cases. American Journal of Surgical Pathology, 42(6), 778\u2013785. https:\/\/doi.org\/10.1097\/pas.0000000000001027","journal-title":"American Journal of Surgical Pathology"},{"issue":"6","key":"10204_CR25","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/his.12771","volume":"67","author":"K Thway","year":"2015","unstructured":"Thway, K., Jordan, S., Fisher, C., & Nicholson, A. G. (2015). Updates in the approach to intrathoracic sarcomas. Histopathology, 67(6), 755\u2013770. https:\/\/doi.org\/10.1111\/his.12771","journal-title":"Histopathology"},{"key":"10204_CR26","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.anndiagpath.2018.01.004","volume":"34","author":"A Ronchi","year":"2018","unstructured":"Ronchi, A., Cozzolino, I., Zito Marino, F., Accardo, M., Montella, M., Panarese, I., et al. (2018). Extrapleural solitary fibrous tumor: A distinct entity from pleural solitary fibrous tumor. An update on clinical, molecular and diagnostic features. Annals of Diagnostic Pathology, 34, 142\u2013150. https:\/\/doi.org\/10.1016\/j.anndiagpath.2018.01.004","journal-title":"Annals of Diagnostic Pathology"},{"issue":"6","key":"10204_CR27","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.prp.2017.04.026","volume":"213","author":"JM Kim","year":"2017","unstructured":"Kim, J. M., Choi, Y. L., Kim, Y. J., & Park, H. K. (2017). Comparison and evaluation of risk factors for meningeal, pleural, and extrapleural solitary fibrous tumors: A clinicopathological study of 92 cases confirmed by STAT6 immunohistochemical staining. Pathology, Research and Practice, 213(6), 619\u2013625. https:\/\/doi.org\/10.1016\/j.prp.2017.04.026","journal-title":"Pathology, Research and Practice"},{"issue":"13","key":"10204_CR28","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.1002\/cncr.32911","volume":"126","author":"RL Haas","year":"2020","unstructured":"Haas, R. L., Walraven, I., Lecointe-Artzner, E., van Houdt, W. J., Strauss, D., Schrage, Y., et al. (2020). Extrameningeal solitary fibrous tumors-surgery alone or surgery plus perioperative radiotherapy: A retrospective study from the global solitary fibrous tumor initiative in collaboration with the Sarcoma Patients EuroNet. Cancer, 126(13), 3002\u20133012. https:\/\/doi.org\/10.1002\/cncr.32911","journal-title":"Cancer"},{"issue":"5","key":"10204_CR29","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1097\/PAP.0b013e318229c004","volume":"18","author":"M Bisceglia","year":"2011","unstructured":"Bisceglia, M., Galliani, C., Giannatempo, G., Lauriola, W., Bianco, M., D\u2019angelo, V., et al. (2011). Solitary fibrous tumor of the central nervous system: A 15-year literature survey of 220 cases (August 1996\u2013July 2011). Advances in anatomic pathology, 18(5), 356\u2013392.","journal-title":"Advances in anatomic pathology"},{"key":"10204_CR30","doi-asserted-by":"publisher","first-page":"94","DOI":"10.21037\/tgh.2018.11.02","volume":"3","author":"B Davanzo","year":"2018","unstructured":"Davanzo, B., Emerson, R. E., Lisy, M., Koniaris, L. G., & Kays, J. K. (2018). Solitary fibrous tumor. Translational Gastroenterology and Hepatology, 3, 94. https:\/\/doi.org\/10.21037\/tgh.2018.11.02","journal-title":"Translational Gastroenterology and Hepatology"},{"issue":"1","key":"10204_CR31","doi-asserted-by":"publisher","first-page":"W55","DOI":"10.2214\/ajr.09.3379","volume":"195","author":"OJ Wignall","year":"2010","unstructured":"Wignall, O. J., Moskovic, E. C., Thway, K., & Thomas, J. M. (2010). Solitary fibrous tumors of the soft tissues: Review of the imaging and clinical features with histopathologic correlation. AJR. American Journal of Roentgenology, 195(1), W55-62. https:\/\/doi.org\/10.2214\/ajr.09.3379","journal-title":"AJR. American Journal of Roentgenology"},{"key":"10204_CR32","doi-asserted-by":"publisher","first-page":"1385978","DOI":"10.1155\/2020\/1385978","volume":"2020","author":"P Sch\u00f6ffski","year":"2020","unstructured":"Sch\u00f6ffski, P., Timmermans, I., Hompes, D., Stas, M., Sinnaeve, F., De Leyn, P., et al. (2020). Clinical presentation, natural history, and therapeutic approach in patients with solitary fibrous tumor: A retrospective analysis. Sarcoma, 2020, 1385978. https:\/\/doi.org\/10.1155\/2020\/1385978","journal-title":"Sarcoma"},{"issue":"4","key":"10204_CR33","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1385\/mo:20:4:403","volume":"20","author":"H Zafar","year":"2003","unstructured":"Zafar, H., Takimoto, C. H., & Weiss, G. (2003). Doege-Potter syndrome: Hypoglycemia associated with malignant solitary fibrous tumor. Medical Oncology, 20(4), 403\u2013408. https:\/\/doi.org\/10.1385\/mo:20:4:403","journal-title":"Medical Oncology"},{"issue":"7","key":"10204_CR34","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/modpathol.2009.48","volume":"22","author":"SE Steigen","year":"2009","unstructured":"Steigen, S. E., Schaeffer, D. F., West, R. B., & Nielsen, T. O. (2009). Expression of insulin-like growth factor 2 in mesenchymal neoplasms. Modern Pathology, 22(7), 914\u2013921. https:\/\/doi.org\/10.1038\/modpathol.2009.48","journal-title":"Modern Pathology"},{"issue":"4","key":"10204_CR35","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.ajpath.2013.12.016","volume":"184","author":"S Barthelme\u00df","year":"2014","unstructured":"Barthelme\u00df, S., Geddert, H., Boltze, C., Moskalev, E. A., Bieg, M., Sirbu, H., et al. (2014). Solitary fibrous tumors\/hemangiopericytomas with different variants of the NAB2-STAT6 gene fusion are characterized by specific histomorphology and distinct clinicopathological features. American Journal of Pathology, 184(4), 1209\u20131218. https:\/\/doi.org\/10.1016\/j.ajpath.2013.12.016","journal-title":"American Journal of Pathology"},{"issue":"1","key":"10204_CR36","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/jcb.22690","volume":"111","author":"J Kumbrink","year":"2010","unstructured":"Kumbrink, J., Kirsch, K. H., & Johnson, J. P. (2010). EGR1, EGR2, and EGR3 activate the expression of their coregulator NAB2 establishing a negative feedback loop in cells of neuroectodermal and epithelial origin. Journal of Cellular Biochemistry, 111(1), 207\u2013217. https:\/\/doi.org\/10.1002\/jcb.22690","journal-title":"Journal of Cellular Biochemistry"},{"issue":"5","key":"10204_CR37","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1210\/me.2006-0392","volume":"21","author":"MA Lawson","year":"2007","unstructured":"Lawson, M. A., Tsutsumi, R., Zhang, H., Talukdar, I., Butler, B. K., Santos, S. J., et al. (2007). Pulse sensitivity of the luteinizing hormone beta promoter is determined by a negative feedback loop Involving early growth response-1 and Ngfi-A binding protein 1 and 2. Molecular Endocrinology, 21(5), 1175\u20131191. https:\/\/doi.org\/10.1210\/me.2006-0392","journal-title":"Molecular Endocrinology"},{"issue":"52","key":"10204_CR38","doi-asserted-by":"publisher","first-page":"42785","DOI":"10.1074\/jbc.M511079200","volume":"280","author":"J Kumbrink","year":"2005","unstructured":"Kumbrink, J., Gerlinger, M., & Johnson, J. P. (2005). Egr-1 induces the expression of its corepressor nab2 by activation of the nab2 promoter thereby establishing a negative feedback loop. Journal of Biological Chemistry, 280(52), 42785\u201342793. https:\/\/doi.org\/10.1074\/jbc.M511079200","journal-title":"Journal of Biological Chemistry"},{"key":"10204_CR39","doi-asserted-by":"publisher","unstructured":"Kim, J., Kang, S. M., Oh, S. Y., Lee, H. J., Lee, I., Hwang, J. C., et al. (2019). NGFI-A binding protein 2 promotes EGF-Dependent HNSCC cell invasion. Cancers (Basel), 11(3). https:\/\/doi.org\/10.3390\/cancers11030315","DOI":"10.3390\/cancers11030315"},{"key":"10204_CR40","doi-asserted-by":"publisher","first-page":"642547","DOI":"10.3389\/fonc.2021.642547","volume":"11","author":"B Wang","year":"2021","unstructured":"Wang, B., Guo, H., Yu, H., Chen, Y., Xu, H., & Zhao, G. (2021). The role of the transcription factor EGR1 in cancer. Frontiers in Oncology, 11, 642547. https:\/\/doi.org\/10.3389\/fonc.2021.642547","journal-title":"Frontiers in Oncology"},{"key":"10204_CR41","doi-asserted-by":"publisher","unstructured":"Martin-Broto, J., Mondaza-Hernandez, J. L., Moura, D. S., & Hindi, N. (2021). A Comprehensive review on solitary fibrous tumor: New insights for New Horizons. Cancers (Basel), 13(12). https:\/\/doi.org\/10.3390\/cancers13122913","DOI":"10.3390\/cancers13122913"},{"key":"10204_CR42","doi-asserted-by":"publisher","first-page":"153477","DOI":"10.1016\/j.prp.2021.153477","volume":"223","author":"G Karpathiou","year":"2021","unstructured":"Karpathiou, G., Papoudou-Bai, A., Ferrand, E., Dumollard, J. M., & Peoc\u2019h, M. (2021). STAT6: A review of a signaling pathway implicated in various diseases with a special emphasis in its usefulness in pathology. Pathology, Research and Practice, 223, 153477. https:\/\/doi.org\/10.1016\/j.prp.2021.153477","journal-title":"Pathology, Research and Practice"},{"key":"10204_CR43","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.semcancer.2019.10.002","volume":"60","author":"Y Verhoeven","year":"2020","unstructured":"Verhoeven, Y., Tilborghs, S., Jacobs, J., De Waele, J., Quatannens, D., Deben, C., et al. (2020). The potential and controversy of targeting STAT family members in cancer. Seminars in Cancer Biology, 60, 41\u201356. https:\/\/doi.org\/10.1016\/j.semcancer.2019.10.002","journal-title":"Seminars in Cancer Biology"},{"issue":"1","key":"10204_CR44","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3892\/ol.2020.11614","volume":"20","author":"Y Delgado-Ramirez","year":"2020","unstructured":"Delgado-Ramirez, Y., Colly, V., Gonzalez, G. V., & Leon-Cabrera, S. (2020). Signal transducer and activator of transcription 6 as a target in colon cancer therapy. Oncology Letters, 20(1), 455\u2013464. https:\/\/doi.org\/10.3892\/ol.2020.11614","journal-title":"Oncology Letters"},{"issue":"11","key":"10204_CR45","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1172\/jci1404","volume":"101","author":"JL Schwachtgen","year":"1998","unstructured":"Schwachtgen, J. L., Houston, P., Campbell, C., Sukhatme, V., & Braddock, M. (1998). Fluid shear stress activation of egr-1 transcription in cultured human endothelial and epithelial cells is mediated via the extracellular signal-related kinase 1\/2 mitogen-activated protein kinase pathway. The Journal of Clinical Investigation, 101(11), 2540\u20132549. https:\/\/doi.org\/10.1172\/jci1404","journal-title":"The Journal of Clinical Investigation"},{"issue":"1","key":"10204_CR46","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.canlet.2013.12.001","volume":"346","author":"RC Ji","year":"2014","unstructured":"Ji, R. C. (2014). Hypoxia and lymphangiogenesis in tumor microenvironment and metastasis. Cancer Letters, 346(1), 6\u201316. https:\/\/doi.org\/10.1016\/j.canlet.2013.12.001","journal-title":"Cancer Letters"},{"issue":"2","key":"10204_CR47","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/sj.cgt.7700896","volume":"13","author":"V Baron","year":"2006","unstructured":"Baron, V., Adamson, E. D., Calogero, A., Ragona, G., & Mercola, D. (2006). The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFbeta1, PTEN, p53, and fibronectin. Cancer Gene Therapy, 13(2), 115\u2013124. https:\/\/doi.org\/10.1038\/sj.cgt.7700896","journal-title":"Cancer Gene Therapy"},{"issue":"35","key":"10204_CR48","doi-asserted-by":"publisher","first-page":"6241","DOI":"10.1038\/s41388-019-0873-8","volume":"38","author":"L Li","year":"2019","unstructured":"Li, L., Ameri, A. H., Wang, S., Jansson, K. H., Casey, O. M., Yang, Q., et al. (2019). EGR1 regulates angiogenic and osteoclastogenic factors in prostate cancer and promotes metastasis. Oncogene, 38(35), 6241\u20136255. https:\/\/doi.org\/10.1038\/s41388-019-0873-8","journal-title":"Oncogene"},{"issue":"7\u20138","key":"10204_CR49","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.cancergen.2016.05.071","volume":"209","author":"NV Guseva","year":"2016","unstructured":"Guseva, N. V., Tanas, M. R., Stence, A. A., Sompallae, R., Schade, J. C., Bossler, A. D., et al. (2016). The NAB2-STAT6 gene fusion in solitary fibrous tumor can be reliably detected by anchored multiplexed PCR for targeted next-generation sequencing. Cancer Genetics, 209(7\u20138), 303\u2013312. https:\/\/doi.org\/10.1016\/j.cancergen.2016.05.071","journal-title":"Cancer Genetics"},{"issue":"5","key":"10204_CR50","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41379-021-00980-x","volume":"35","author":"MD Lanic","year":"2022","unstructured":"Lanic, M. D., Le Loarer, F., Rainville, V., Sater, V., Viennot, M., Beaussire, L., et al. (2022). Detection of sarcoma fusions by a next-generation sequencing based-ligation-dependent multiplex RT-PCR assay. Modern Pathology, 35(5), 649\u2013663. https:\/\/doi.org\/10.1038\/s41379-021-00980-x","journal-title":"Modern Pathology"},{"issue":"11","key":"10204_CR51","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.prp.2017.08.011","volume":"213","author":"B Rekhi","year":"2017","unstructured":"Rekhi, B., Shetty, O., Tripathi, P., Bapat, P., Ramadwar, M., Bajpai, J., et al. (2017). Molecular characterization of a series of solitary fibrous tumors, including immunohistochemical expression of STAT6 and NATB2-STAT6 fusion transcripts, using Reverse Transcriptase(RT)-Polymerase chain reaction(PCR) technique: An Indian experience. Pathology, Research and Practice, 213(11), 1404\u20131411. https:\/\/doi.org\/10.1016\/j.prp.2017.08.011","journal-title":"Pathology, Research and Practice"},{"issue":"6","key":"10204_CR52","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1136\/archdischild-2013-304340","volume":"98","author":"S Behjati","year":"2013","unstructured":"Behjati, S., & Tarpey, P. S. (2013). What is next generation sequencing? Archives of Disease in Childhood. Education and Practice Edition, 98(6), 236\u2013238. https:\/\/doi.org\/10.1136\/archdischild-2013-304340","journal-title":"Archives of Disease in Childhood. Education and Practice Edition"},{"issue":"2","key":"10204_CR53","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.canlet.2012.11.004","volume":"340","author":"M Tuna","year":"2013","unstructured":"Tuna, M., & Amos, C. I. (2013). Genomic sequencing in cancer. Cancer Letters, 340(2), 161\u2013170. https:\/\/doi.org\/10.1016\/j.canlet.2012.11.004","journal-title":"Cancer Letters"},{"key":"10204_CR54","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.canlet.2020.01.020","volume":"474","author":"J Zhao","year":"2020","unstructured":"Zhao, J., Dean, D. C., Hornicek, F. J., Yu, X., & Duan, Z. (2020). Emerging next-generation sequencing-based discoveries for targeted osteosarcoma therapy. Cancer Letters, 474, 158\u2013167. https:\/\/doi.org\/10.1016\/j.canlet.2020.01.020","journal-title":"Cancer Letters"},{"issue":"3","key":"10204_CR55","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/cas.13505","volume":"109","author":"H Nakagawa","year":"2018","unstructured":"Nakagawa, H., & Fujita, M. (2018). Whole genome sequencing analysis for cancer genomics and precision medicine. Cancer Science, 109(3), 513\u2013522. https:\/\/doi.org\/10.1111\/cas.13505","journal-title":"Cancer Science"},{"issue":"2","key":"10204_CR56","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrg3642","volume":"15","author":"D Sims","year":"2014","unstructured":"Sims, D., Sudbery, I., Ilott, N. E., Heger, A., & Ponting, C. P. (2014). Sequencing depth and coverage: Key considerations in genomic analyses. Nature Reviews Genetics, 15(2), 121\u2013132. https:\/\/doi.org\/10.1038\/nrg3642","journal-title":"Nature Reviews Genetics"},{"issue":"1","key":"10204_CR57","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s11684-012-0182-x","volume":"6","author":"H Dong","year":"2012","unstructured":"Dong, H., & Wang, S. (2012). Exploring the cancer genome in the era of next-generation sequencing. Frontiers in Medicine, 6(1), 48\u201355. https:\/\/doi.org\/10.1007\/s11684-012-0182-x","journal-title":"Frontiers in Medicine"},{"key":"10204_CR58","doi-asserted-by":"publisher","unstructured":"Hrdlickova, R., Toloue, M., & Tian, B. (2017). RNA-Seq methods for transcriptome analysis. Wiley Interdiscip Rev RNA, 8(1). https:\/\/doi.org\/10.1002\/wrna.1364","DOI":"10.1002\/wrna.1364"},{"issue":"12","key":"10204_CR59","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1038\/nm.3729","volume":"20","author":"Z Zheng","year":"2014","unstructured":"Zheng, Z., Liebers, M., Zhelyazkova, B., Cao, Y., Panditi, D., Lynch, K. D., et al. (2014). Anchored multiplex PCR for targeted next-generation sequencing. Nature Medicine, 20(12), 1479\u20131484. https:\/\/doi.org\/10.1038\/nm.3729","journal-title":"Nature Medicine"},{"key":"10204_CR60","doi-asserted-by":"publisher","first-page":"5227","DOI":"10.2147\/ott.S168045","volume":"11","author":"Z Song","year":"2018","unstructured":"Song, Z., Yang, F., Zhang, Y., Fan, P., Liu, G., Li, C., et al. (2018). Surgical therapy and next-generation sequencing-based genetic alteration analysis of malignant solitary fibrous tumor of the pleura. Oncotargets and Therapy, 11, 5227\u20135238. https:\/\/doi.org\/10.2147\/ott.S168045","journal-title":"Oncotargets and Therapy"},{"issue":"2","key":"10204_CR61","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/2524","volume":"20","author":"D Pinkel","year":"1998","unstructured":"Pinkel, D., Segraves, R., Sudar, D., Clark, S., Poole, I., Kowbel, D., et al. (1998). High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nature Genetics, 20(2), 207\u2013211. https:\/\/doi.org\/10.1038\/2524","journal-title":"Nature Genetics"},{"issue":"2","key":"10204_CR62","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/cjp2.64","volume":"3","author":"L Cheng","year":"2017","unstructured":"Cheng, L., Zhang, S., Wang, L., MacLennan, G. T., & Davidson, D. D. (2017). Fluorescence in situ hybridization in surgical pathology: Principles and applications. Journal of Pathology: Clinical Research, 3(2), 73\u201399. https:\/\/doi.org\/10.1002\/cjp2.64","journal-title":"Journal of Pathology: Clinical Research"},{"issue":"6","key":"10204_CR63","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1136\/jclinpath-2016-204088","volume":"70","author":"E Kouba","year":"2017","unstructured":"Kouba, E., Simper, N. B., Chen, S., Williamson, S. R., Grignon, D. J., Eble, J. N., et al. (2017). Solitary fibrous tumour of the genitourinary tract: A clinicopathological study of 11 cases and their association with the NAB2-STAT6 fusion gene. Journal of Clinical Pathology, 70(6), 508\u2013514. https:\/\/doi.org\/10.1136\/jclinpath-2016-204088","journal-title":"Journal of Clinical Pathology"},{"issue":"Suppl 2","key":"10204_CR64","doi-asserted-by":"publisher","first-page":"S307","DOI":"10.4103\/0975-7406.100281","volume":"4","author":"J Duraiyan","year":"2012","unstructured":"Duraiyan, J., Govindarajan, R., Kaliyappan, K., & Palanisamy, M. (2012). Applications of immunohistochemistry. Journal of Pharmacy and Bioallied Sciences, 4(Suppl 2), S307-309. https:\/\/doi.org\/10.4103\/0975-7406.100281","journal-title":"Journal of Pharmacy and Bioallied Sciences"},{"issue":"1","key":"10204_CR65","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/his.12377","volume":"65","author":"M Vivero","year":"2014","unstructured":"Vivero, M., Doyle, L. A., Fletcher, C. D., Mertens, F., & Hornick, J. L. (2014). GRIA2 is a novel diagnostic marker for solitary fibrous tumour identified through gene expression profiling. Histopathology, 65(1), 71\u201380. https:\/\/doi.org\/10.1111\/his.12377","journal-title":"Histopathology"},{"issue":"3","key":"10204_CR66","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/modpathol.2013.164","volume":"27","author":"LA Doyle","year":"2014","unstructured":"Doyle, L. A., Vivero, M., Fletcher, C. D., Mertens, F., & Hornick, J. L. (2014). Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics. Modern Pathology, 27(3), 390\u2013395. https:\/\/doi.org\/10.1038\/modpathol.2013.164","journal-title":"Modern Pathology"},{"issue":"5","key":"10204_CR67","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00401-013-1117-6","volume":"125","author":"L Schweizer","year":"2013","unstructured":"Schweizer, L., Koelsche, C., Sahm, F., Piro, R. M., Capper, D., Reuss, D. E., et al. (2013). Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 protein. Acta Neuropathologica, 125(5), 651\u2013658. https:\/\/doi.org\/10.1007\/s00401-013-1117-6","journal-title":"Acta Neuropathologica"},{"issue":"1","key":"10204_CR68","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/his.12298","volume":"64","author":"M Miettinen","year":"2014","unstructured":"Miettinen, M. (2014). Immunohistochemistry of soft tissue tumours - review with emphasis on 10 markers. Histopathology, 64(1), 101\u2013118. https:\/\/doi.org\/10.1111\/his.12298","journal-title":"Histopathology"},{"issue":"10","key":"10204_CR69","first-page":"13166","volume":"8","author":"Y Han","year":"2015","unstructured":"Han, Y., Zhang, Q., Yu, X., Han, X., Wang, H., Xu, Y., et al. (2015). Immunohistochemical detection of STAT6, CD34, CD99 and BCL-2 for diagnosing solitary fibrous tumors\/hemangiopericytomas. International Journal of Clinical and Experimental Pathology, 8(10), 13166\u201313175.","journal-title":"International Journal of Clinical and Experimental Pathology"},{"issue":"7","key":"10204_CR70","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1097\/00000478-199807000-00008","volume":"22","author":"S Suster","year":"1998","unstructured":"Suster, S., Fisher, C., & Moran, C. A. (1998). Expression of bcl-2 oncoprotein in benign and malignant spindle cell tumors of soft tissue, skin, serosal surfaces, and gastrointestinal tract. American Journal of Surgical Pathology, 22(7), 863\u2013872. https:\/\/doi.org\/10.1097\/00000478-199807000-00008","journal-title":"American Journal of Surgical Pathology"},{"issue":"9","key":"10204_CR71","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/modpathol.2013.247","volume":"27","author":"LA Doyle","year":"2014","unstructured":"Doyle, L. A., Tao, D., & Mari\u00f1o-Enr\u00edquez, A. (2014). STAT6 is amplified in a subset of dedifferentiated liposarcoma. Modern Pathology, 27(9), 1231\u20131237. https:\/\/doi.org\/10.1038\/modpathol.2013.247","journal-title":"Modern Pathology"},{"issue":"5","key":"10204_CR72","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1309\/ajcpn25njtounpnf","volume":"143","author":"EG Demicco","year":"2015","unstructured":"Demicco, E. G., Harms, P. W., Patel, R. M., Smith, S. C., Ingram, D., Torres, K., et al. (2015). Extensive survey of STAT6 expression in a large series of mesenchymal tumors. American Journal of Clinical Pathology, 143(5), 672\u2013682. https:\/\/doi.org\/10.1309\/ajcpn25njtounpnf","journal-title":"American Journal of Clinical Pathology"},{"key":"10204_CR73","doi-asserted-by":"publisher","first-page":"153803","DOI":"10.1016\/j.prp.2022.153803","volume":"232","author":"G Broggi","year":"2022","unstructured":"Broggi, G., Mazzucchelli, M., Covello, R., Casini, B., Barbagallo, G. M. V., Salvatorelli, L., et al. (2022). A mesenchymal chondrosarcoma with aberrant nuclear expression of STAT6: A potential diagnostic pitfall. Pathology, Research and Practice, 232, 153803. https:\/\/doi.org\/10.1016\/j.prp.2022.153803","journal-title":"Pathology, Research and Practice"},{"key":"10204_CR74","doi-asserted-by":"publisher","unstructured":"Ghanim, B., Baier, D., Pirker, C., M\u00fcllauer, L., Sinn, K., Lang, G., et al. (2022). Trabectedin is active against two novel, patient-derived solitary fibrous pleural tumor cell lines and synergizes with ponatinib. Cancers (Basel), 14(22). https:\/\/doi.org\/10.3390\/cancers14225602","DOI":"10.3390\/cancers14225602"},{"issue":"8","key":"10204_CR75","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1038\/modpathol.2015.70","volume":"28","author":"GP Dagrada","year":"2015","unstructured":"Dagrada, G. P., Spagnuolo, R. D., Mauro, V., Tamborini, E., Cesana, L., Gronchi, A., et al. (2015). Solitary fibrous tumors: Loss of chimeric protein expression and genomic instability mark dedifferentiation. Modern Pathology, 28(8), 1074\u20131083. https:\/\/doi.org\/10.1038\/modpathol.2015.70","journal-title":"Modern Pathology"},{"issue":"4","key":"10204_CR76","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1177\/107327480601300403","volume":"13","author":"LA Robinson","year":"2006","unstructured":"Robinson, L. A. (2006). Solitary fibrous tumor of the pleura. Cancer Control, 13(4), 264\u2013269. https:\/\/doi.org\/10.1177\/107327480601300403","journal-title":"Cancer Control"},{"issue":"4","key":"10204_CR77","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/MCP.0b013e328352f696","volume":"18","author":"G Cardillo","year":"2012","unstructured":"Cardillo, G., Lococo, F., Carleo, F., & Martelli, M. (2012). Solitary fibrous tumors of the pleura. Current Opinion in Pulmonary Medicine, 18(4), 339\u2013346. https:\/\/doi.org\/10.1097\/MCP.0b013e328352f696","journal-title":"Current Opinion in Pulmonary Medicine"},{"issue":"2","key":"10204_CR78","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.athoracsur.2012.04.028","volume":"94","author":"B Lahon","year":"2012","unstructured":"Lahon, B., Mercier, O., Fadel, E., Ghigna, M. R., Petkova, B., Mussot, S., et al. (2012). Solitary fibrous tumor of the pleura: Outcomes of 157 complete resections in a single center. Annals of Thoracic Surgery, 94(2), 394\u2013400. https:\/\/doi.org\/10.1016\/j.athoracsur.2012.04.028","journal-title":"Annals of Thoracic Surgery"},{"issue":"11","key":"10204_CR79","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1097\/JTO.0b013e3182653d64","volume":"7","author":"F Lococo","year":"2012","unstructured":"Lococo, F., Cesario, A., Cardillo, G., Filosso, P., Galetta, D., Carbone, L., et al. (2012). Malignant solitary fibrous tumors of the pleura: Retrospective review of a multicenter series. Journal of Thoracic Oncology, 7(11), 1698\u20131706. https:\/\/doi.org\/10.1097\/JTO.0b013e3182653d64","journal-title":"Journal of Thoracic Oncology"},{"issue":"1","key":"10204_CR80","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/coc.0000000000000218","volume":"41","author":"AJ Bishop","year":"2018","unstructured":"Bishop, A. J., Zagars, G. K., Demicco, E. G., Wang, W. L., Feig, B. W., & Guadagnolo, B. A. (2018). Soft tissue solitary fibrous tumor: Combined surgery and radiation therapy results in excellent local control. American Journal of Clinical Oncology, 41(1), 81\u201385. https:\/\/doi.org\/10.1097\/coc.0000000000000218","journal-title":"American Journal of Clinical Oncology"},{"issue":"4","key":"10204_CR81","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3109\/0284186x.2011.626450","volume":"51","author":"A Constantinidou","year":"2012","unstructured":"Constantinidou, A., Jones, R. L., Olmos, D., Thway, K., Fisher, C., Al-Muderis, O., et al. (2012). Conventional anthracycline-based chemotherapy has limited efficacy in solitary fibrous tumour. Acta Oncologica, 51(4), 550\u2013554. https:\/\/doi.org\/10.3109\/0284186x.2011.626450","journal-title":"Acta Oncologica"},{"key":"10204_CR82","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/1471-2407-13-109","volume":"13","author":"A Levard","year":"2013","unstructured":"Levard, A., Derbel, O., M\u00e9eus, P., Ranch\u00e8re, D., Ray-Coquard, I., Blay, J. Y., et al. (2013). Outcome of patients with advanced solitary fibrous tumors: The Centre L\u00e9on B\u00e9rard experience. BMC Cancer, 13, 109. https:\/\/doi.org\/10.1186\/1471-2407-13-109","journal-title":"BMC Cancer"},{"issue":"10","key":"10204_CR83","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1016\/j.ejca.2013.03.017","volume":"49","author":"S Stacchiotti","year":"2013","unstructured":"Stacchiotti, S., Libertini, M., Negri, T., Palassini, E., Gronchi, A., Fatigoni, S., et al. (2013). Response to chemotherapy of solitary fibrous tumour: A retrospective study. European Journal of Cancer, 49(10), 2376\u20132383. https:\/\/doi.org\/10.1016\/j.ejca.2013.03.017","journal-title":"European Journal of Cancer"},{"issue":"1","key":"10204_CR84","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/2045-3329-3-7","volume":"3","author":"MS Park","year":"2013","unstructured":"Park, M. S., Ravi, V., Conley, A., Patel, S. R., Trent, J. C., Lev, D. C., et al. (2013). The role of chemotherapy in advanced solitary fibrous tumors: A retrospective analysis. Clinical Sarcoma Research, 3(1), 7. https:\/\/doi.org\/10.1186\/2045-3329-3-7","journal-title":"Clinical Sarcoma Research"},{"key":"10204_CR85","doi-asserted-by":"publisher","unstructured":"Outani, H., Kobayashi, E., Wasa, J., Saito, M., Takenaka, S., Hayakawa, K., et al. (2021). Clinical outcomes of patients with metastatic solitary fibrous tumors: A Japanese musculoskeletal oncology group (JMOG) Multiinstitutional study Annals of Surgical Oncology, 28(7), 3893\u20133901. https:\/\/doi.org\/10.1245\/s10434-020-09306-8","DOI":"10.1245\/s10434-020-09306-8"},{"key":"10204_CR86","doi-asserted-by":"publisher","unstructured":"Stacchiotti, S., Tortoreto, M., Bozzi, F., Tamborini, E., Morosi, C., Messina, A., et al. (2013). Dacarbazine in solitary fibrous tumor: A case series analysis and preclinical evidence vis-a-vis temozolomide and antiangiogenics. Clinical Cancer Research, 19(18), 5192\u20135201. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-13-0776","DOI":"10.1158\/1078-0432.Ccr-13-0776"},{"key":"10204_CR87","doi-asserted-by":"publisher","unstructured":"Khalifa, J., Ouali, M., Chaltiel, L., Le Guellec, S., Le Cesne, A., Blay, J. Y., et al. (2015). Efficacy of trabectedin in malignant solitary fibrous tumors: A retrospective analysis from the French Sarcoma Group. BMC Cancer, 15, 700. https:\/\/doi.org\/10.1186\/s12885-015-1697-8","DOI":"10.1186\/s12885-015-1697-8"},{"issue":"6","key":"10204_CR88","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.ejca.2015.01.006","volume":"51","author":"A Le Cesne","year":"2015","unstructured":"Le Cesne, A., Ray-Coquard, I., Duffaud, F., Chevreau, C., Penel, N., Bui Nguyen, B., et al. (2015). Trabectedin in patients with advanced soft tissue sarcoma: A retrospective national analysis of the French Sarcoma Group. European Journal of Cancer, 51(6), 742\u2013750. https:\/\/doi.org\/10.1016\/j.ejca.2015.01.006","journal-title":"European Journal of Cancer"},{"issue":"6","key":"10204_CR89","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1002\/cncr.32661","volume":"126","author":"H Kobayashi","year":"2020","unstructured":"Kobayashi, H., Iwata, S., Wakamatsu, T., Hayakawa, K., Yonemoto, T., Wasa, J., et al. (2020). Efficacy and safety of trabectedin for patients with unresectable and relapsed soft-tissue sarcoma in Japan: A Japanese Musculoskeletal Oncology Group study. Cancer, 126(6), 1253\u20131263. https:\/\/doi.org\/10.1002\/cncr.32661","journal-title":"Cancer"},{"issue":"19","key":"10204_CR90","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1200\/jco.2008.20.9890","volume":"27","author":"S George","year":"2009","unstructured":"George, S., Merriam, P., Maki, R. G., Van den Abbeele, A. D., Yap, J. T., Akhurst, T., et al. (2009). Multicenter phase II trial of sunitinib in the treatment of nongastrointestinal stromal tumor sarcomas. Journal of Clinical Oncology, 27(19), 3154\u20133160. https:\/\/doi.org\/10.1200\/jco.2008.20.9890","journal-title":"Journal of Clinical Oncology"},{"issue":"5","key":"10204_CR91","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1158\/1535-7163.Mct-09-1205","volume":"9","author":"S Stacchiotti","year":"2010","unstructured":"Stacchiotti, S., Negri, T., Palassini, E., Conca, E., Gronchi, A., Morosi, C., et al. (2010). Sunitinib malate and figitumumab in solitary fibrous tumor: Patterns and molecular bases of tumor response. Molecular Cancer Therapeutics, 9(5), 1286\u20131297. https:\/\/doi.org\/10.1158\/1535-7163.Mct-09-1205","journal-title":"Molecular Cancer Therapeutics"},{"issue":"31","key":"10204_CR92","doi-asserted-by":"publisher","first-page":"e34520","DOI":"10.1097\/md.0000000000034520","volume":"102","author":"P Zhou","year":"2023","unstructured":"Zhou, P., & Xu, X. (2023). Recurrent malignant solitary fibrous tumor of pelvis: A case report and treatment approach. Medicine (Baltimore), 102(31), e34520. https:\/\/doi.org\/10.1097\/md.0000000000034520","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10204_CR93","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1007\/s10637-013-0023-z","volume":"31","author":"T Valentin","year":"2013","unstructured":"Valentin, T., Fournier, C., Penel, N., Bompas, E., Chaigneau, L., Isambert, N., et al. (2013). Sorafenib in patients with progressive malignant solitary fibrous tumors: A subgroup analysis from a phase II study of the French Sarcoma Group (GSF\/GETO). Investigational New Drugs, 31(6), 1626\u20131627. https:\/\/doi.org\/10.1007\/s10637-013-0023-z","journal-title":"Investigational New Drugs"},{"issue":"17","key":"10204_CR94","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1016\/j.ejca.2014.09.004","volume":"50","author":"S Stacchiotti","year":"2014","unstructured":"Stacchiotti, S., Tortoreto, M., Baldi, G. G., Grignani, G., Toss, A., Badalamenti, G., et al. (2014). Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumour. European Journal of Cancer, 50(17), 3021\u20133028. https:\/\/doi.org\/10.1016\/j.ejca.2014.09.004","journal-title":"European Journal of Cancer"},{"key":"10204_CR95","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13569-015-0022-2","volume":"5","author":"M Maruzzo","year":"2015","unstructured":"Maruzzo, M., Martin-Liberal, J., Messiou, C., Miah, A., Thway, K., Alvarado, R., et al. (2015). Pazopanib as first line treatment for solitary fibrous tumours: The Royal Marsden Hospital experience. Clinical Sarcoma Research, 5, 5. https:\/\/doi.org\/10.1186\/s13569-015-0022-2","journal-title":"Clinical Sarcoma Research"},{"issue":"1","key":"10204_CR96","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/s1470-2045(18)30676-4","volume":"20","author":"J Martin-Broto","year":"2019","unstructured":"Martin-Broto, J., Stacchiotti, S., Lopez-Pousa, A., Redondo, A., Bernabeu, D., de Alava, E., et al. (2019). Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: A multicentre, single-arm, phase 2 trial. The lancet Oncology, 20(1), 134\u2013144. https:\/\/doi.org\/10.1016\/s1470-2045(18)30676-4","journal-title":"The lancet Oncology"},{"issue":"3","key":"10204_CR97","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/s1470-2045(19)30826-5","volume":"21","author":"J Martin-Broto","year":"2020","unstructured":"Martin-Broto, J., Cruz, J., Penel, N., Le Cesne, A., Hindi, N., Luna, P., et al. (2020). Pazopanib for treatment of typical solitary fibrous tumours: A multicentre, single-arm, phase 2 trial. The lancet Oncology, 21(3), 456\u2013466. https:\/\/doi.org\/10.1016\/s1470-2045(19)30826-5","journal-title":"The lancet Oncology"},{"issue":"7","key":"10204_CR98","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/bjc.2014.437","volume":"111","author":"M Tazzari","year":"2014","unstructured":"Tazzari, M., Negri, T., Rini, F., Vergani, B., Huber, V., Villa, A., et al. (2014). Adaptive immune contexture at the tumour site and downmodulation of circulating myeloid-derived suppressor cells in the response of solitary fibrous tumour patients to anti-angiogenic therapy. British Journal of Cancer, 111(7), 1350\u20131362. https:\/\/doi.org\/10.1038\/bjc.2014.437","journal-title":"British Journal of Cancer"},{"issue":"2","key":"10204_CR99","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s11060-018-2876-7","volume":"139","author":"D Kamamoto","year":"2018","unstructured":"Kamamoto, D., Ohara, K., Kitamura, Y., Yoshida, K., Kawakami, Y., & Sasaki, H. (2018). Association between programmed cell death ligand-1 expression and extracranial metastasis in intracranial solitary fibrous tumor\/hemangiopericytoma. Journal of Neuro-oncology, 139(2), 251\u2013259. https:\/\/doi.org\/10.1007\/s11060-018-2876-7","journal-title":"Journal of Neuro-oncology"},{"issue":"12","key":"10204_CR100","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1038\/s41379-019-0312-y","volume":"32","author":"AR Dancsok","year":"2019","unstructured":"Dancsok, A. R., Setsu, N., Gao, D., Blay, J. Y., Thomas, D., Maki, R. G., et al. (2019). Expression of lymphocyte immunoregulatory biomarkers in bone and soft-tissue sarcomas. Modern Pathology, 32(12), 1772\u20131785. https:\/\/doi.org\/10.1038\/s41379-019-0312-y","journal-title":"Modern Pathology"},{"issue":"3","key":"10204_CR101","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1159\/000484041","volume":"10","author":"JT Boothe","year":"2017","unstructured":"Boothe, J. T., Budd, G. T., Smolkin, M. B., & Ma, P. C. (2017). Durable near-complete response to Anti-PD-1 checkpoint immunotherapy in a refractory malignant solitary fibrous tumor of the Pleura. Case Reports in Oncology, 10(3), 998\u20131005. https:\/\/doi.org\/10.1159\/000484041","journal-title":"Case Reports in Oncology"},{"issue":"1","key":"10204_CR102","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1001\/jamaoncol.2017.1617","volume":"4","author":"M Toulmonde","year":"2018","unstructured":"Toulmonde, M., Penel, N., Adam, J., Chevreau, C., Blay, J. Y., Le Cesne, A., et al. (2018). Use of PD-1 targeting, macrophage infiltration, and IDO pathway activation in sarcomas: A Phase 2 clinical trial. JAMA Oncology, 4(1), 93\u201397. https:\/\/doi.org\/10.1001\/jamaoncol.2017.1617","journal-title":"JAMA Oncology"},{"key":"10204_CR103","doi-asserted-by":"publisher","unstructured":"Li, Y., Nguyen, J. T., Ammanamanchi, M., Zhou, Z., Harbut, E. F., Mondaza-Hernandez, J. L., et al. (2023). Reduction of tumor growth with RNA-targeting treatment of the NAB2-STAT6 fusion transcript in solitary fibrous tumor models. Cancers (Basel), 15(12). https:\/\/doi.org\/10.3390\/cancers15123127","DOI":"10.3390\/cancers15123127"},{"issue":"3","key":"10204_CR104","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s00428-019-02650-5","volume":"476","author":"G Bianchi","year":"2020","unstructured":"Bianchi, G., Sambri, A., Pedrini, E., Pazzaglia, L., Sangiorgi, L., Ruengwanichayakun, P., et al. (2020). Histological and molecular features of solitary fibrous tumor of the extremities: Clinical correlation. Virchows Archiv, 476(3), 445\u2013454. https:\/\/doi.org\/10.1007\/s00428-019-02650-5","journal-title":"Virchows Archiv"},{"issue":"3","key":"10204_CR105","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/pin.12894","volume":"70","author":"I Machado","year":"2020","unstructured":"Machado, I., Nieto-Morales, G., Cruz, J., Navarro, S., Giner, F., Ferrandez, A., et al. (2020). Controversial issues in soft tissue solitary fibrous tumors: A pathological and molecular review. Pathology International, 70(3), 129\u2013139. https:\/\/doi.org\/10.1111\/pin.12894","journal-title":"Pathology International"},{"key":"10204_CR106","doi-asserted-by":"publisher","unstructured":"Hong, J. H., Noh, M. G., Akanda, M. R., Kim, Y. J., Kim, S. H., Jung, T. Y., et al. (2021). Solitary fibrous tumor\/hemangiopericytoma metastasizes extracranially, associated with altered expression of WNT5A and MMP9. Cancers (Basel), 13(5). https:\/\/doi.org\/10.3390\/cancers13051142","DOI":"10.3390\/cancers13051142"},{"issue":"3","key":"10204_CR107","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/path.2715","volume":"221","author":"M Hajdu","year":"2010","unstructured":"Hajdu, M., Singer, S., Maki, R. G., Schwartz, G. K., Keohan, M. L., & Antonescu, C. R. (2010). IGF2 over-expression in solitary fibrous tumours is independent of anatomical location and is related to loss of imprinting. The Journal of Pathology, 221(3), 300\u2013307. https:\/\/doi.org\/10.1002\/path.2715","journal-title":"The Journal of Pathology"},{"issue":"6","key":"10204_CR108","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1002\/cncr.28506","volume":"120","author":"Y Yamada","year":"2014","unstructured":"Yamada, Y., Kohashi, K., Fushimi, F., Takahashi, Y., Setsu, N., Endo, M., et al. (2014). Activation of the Akt-mTOR pathway and receptor tyrosine kinase in patients with solitary fibrous tumors. Cancer, 120(6), 864\u2013876. https:\/\/doi.org\/10.1002\/cncr.28506","journal-title":"Cancer"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-024-10204-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10555-024-10204-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-024-10204-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T17:10:37Z","timestamp":1731345037000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10555-024-10204-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,9]]},"references-count":108,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10204"],"URL":"https:\/\/doi.org\/10.1007\/s10555-024-10204-8","relation":{},"ISSN":["0167-7659","1573-7233"],"issn-type":[{"value":"0167-7659","type":"print"},{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,9]]},"assertion":[{"value":"21 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"N\/A","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}